EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between Respiratory Virus Infection and Development of De Novo Donor-Specific Antibody in Lung Transplant Recipients

Anoma Nellore iD, Julie Houp, John T Killian, Ajit P Limaye, Cynthia E Fisher iD

Viruses · 2024

DOI: 10.3390/v16101574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Anoma Nellore und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Transplant Recipients, Respiratory Tract Infections, Tissue Donors. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, AN Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic lung allograft dysfunction (CLAD) is the most common cause of long-term lung allograft failure. Several factors, including respiratory virus infection (RVI), have been associated with CLAD development, but the underlying mechanisms of these associations are not well understood. We hypothesize that RVI in lung transplant recipients elicits the development of donor-specific antibodies (DSAs), thus providing a mechanistic link between RVI and CLAD development. To test this hypothesis, we retrospectively evaluated for the presence of HLA antibodies in a cohort of lung transplant recipients with symptomatic RVI within the first four months post-transplant using sera at two time points (at/directly after the transplant and following RVI) and time-matched controls without RVI (post-transplant). We found a trend toward the development of de novo DSAs in those with symptomatic RVI versus controls [6/21 (29%) vs. 1/21 (5%), respectively, p = 0.09]. No cases or controls had DSA at baseline. We also found increased rates of CLAD and death among those who developed class II DSA versus those who did not (CLAD: 5/7 (71.4%) vs. 19/34 (54.3%), death: 5/7 (71.4%) vs. 17/35 (48.6%)). Prospective studies evaluating the temporal development of DSA after RVI in lung transplant patients and the subsequent outcomes are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationTransplant RecipientsRespiratory Tract InfectionsTissue DonorsHumansMaleFemaleMiddle AgedRetrospective StudiesAdultGraft RejectionHLA AntigensAgedIsoantibodiesVirus Diseases

Stichwörter der Autor:innen

HLA antibodychronic lung allograft dysfunctiondonor-specific antibodylung transplantrespiratory viral infection

Substanzen

HLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Division of Transplant Surgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Division of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Division of Infectious Diseases, University of California at San Francisco, San Francisco, CA 94143, USA.
  • Division of Infectious Diseases, University of Washington, Seattle, WA 98195, USA.

ORCID-Profile: Anoma Nellore, Cynthia E Fisher

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • AN Grant
  • JTK Grant
  • APL Grant
  • CEF Grant

Zitieren

APA

Nellore, A., Houp, J., Killian, J. T., Limaye, A. P., & Fisher, C. E. (2024). Association between Respiratory Virus Infection and Development of De Novo Donor-Specific Antibody in Lung Transplant Recipients. Viruses. https://doi.org/10.3390/v16101574

Vancouver

Nellore A, Houp J, Killian JT, Limaye AP, Fisher CE. Association between Respiratory Virus Infection and Development of De Novo Donor-Specific Antibody in Lung Transplant Recipients. Viruses. 2024. doi:10.3390/v16101574

BibTeX
@article{Nellore2024,
  author = {Nellore, Anoma and Houp, Julie and Killian, John T and Limaye, Ajit P and Fisher, Cynthia E},
  title = {Association between Respiratory Virus Infection and Development of De Novo Donor-Specific Antibody in Lung Transplant Recipients},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101574}
}
Kostenlos starten →